Management of Severe Anti-Tumor Necrosis Factor (TNF) Induced Psoriasis in Patients with Inflammatory Bowel Disease

被引：1
|
作者：
Gold, Stephanie L. [1 ]
Cohen-Mekelburg, Shirley [1 ]
Schneider, Yecheskel [1 ]
Steinlauf, Adam [2 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-01732
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1732
引用
收藏
页码：S827 / S827
页数：1
相关论文
共 50 条
  • [31] Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
    Fernandes, Carlos
    Allocca, Mariangela
    Danese, Silvio
    Fiorino, Gionata
    IMMUNOTHERAPY, 2015, 7 (02) : 175 - 190
  • [32] Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
    Vera E. R. Asscher
    Quirine van der Vliet
    Karen van der Aalst
    Anniek van der Aalst
    Eelco C. Brand
    Andrea E. van der Meulen-de Jong
    Bas Oldenburg
    Marieke J. Pierik
    Bas van Tuyl
    Nofel Mahmmod
    P. W. Jeroen Maljaars
    Herma H. Fidder
    International Journal of Colorectal Disease, 2020, 35 : 2331 - 2338
  • [33] Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
    Asscher, Vera E. R.
    van der Vliet, Quirine
    van der Aalst, Karen
    van der Aalst, Anniek
    Brand, Eelco C.
    van der Meulen-de Jong, Andrea E.
    Oldenburg, Bas
    Pierik, Marieke J.
    van Tuyl, Bas
    Mahmmod, Nofel
    Maljaars, P. W. Jeroen
    Fidder, Herma H.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (12) : 2331 - 2338
  • [34] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
  • [35] Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Cheon, Jae Hee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 769 - 777
  • [36] Pulmonary lesions in patients with inflammatory bowel disease - the baseline and under anti-tumor necrosis factor therapy
    Borisov, Sergey
    Frolova, Ksenia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications
    Kang, Elise
    Khalili, Ali
    Splawski, Judy
    Sferra, Thomas J.
    Moses, Jonathan
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2018, 21 (04) : 329 - 335
  • [38] Malignancy Outcomes in Inflammatory Bowel Disease Patients on Immune Modulators and Anti-Tumor Necrosis Factor Therapy
    Patel, Umangi
    Lichtenstein, Gary
    Scott, Frank
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S484 - S484
  • [39] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [40] Effects of Anti-Tumor Necrosis Factor Use on Colorectal Cancer Outcomes in Patients with Inflammatory Bowel Disease
    Luo, William Y.
    Bryant, Alex K.
    Stringfield, Sarah
    Murphy, James D.
    Eisenstein, Samuel
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : E105 - E105
12345